Cage Pharma is a pre-clinical biopharmaceutical company that develops new drugs targeting the metabolism of tumors.
Cage Pharma has raised $137K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
Cage Pharma's investors include Catalio Capital Management.
Cage Pharma is headquartered in Baltimore, United States.
Cage Pharma is a pre-clinical biopharmaceutical company that develops new drugs targeting the metabolism of tumors.
Cage Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cage Pharma — Funding & Investors." VCBacked, May 31, 2024, https://www.vcbacked.co/company/cage-pharma. Accessed August 13, 2026.
VCBacked. (2024). Cage Pharma — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/cage-pharma
{{cite web |title=Cage Pharma — Funding & Investors |url=https://www.vcbacked.co/company/cage-pharma |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated